CBLL vs PRCT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CBLL · Ceribell$26.59 ▲ 2.23%
PRCT · PROCEPT BioRobotics$20.62 ▲ 1.73%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CBLL +125.7%
- PRCT -33.4%
Head to head
| Metric | CBLL | PRCT |
|---|---|---|
| Price | $26.59 | $20.62 |
| Change today | ▲ 2.23% | ▲ 1.73% |
| Market cap | $1.03B | $1.19B |
| Return, 3 months | +37.8% | -5.0% |
| Return, year to date | +21.2% | -34.5% |
| Return, 1 year | +122.0% | -35.4% |
| P/E (TTM) | – | – |
| P/B | 8.8 | 3.6 |
| P/E percentile vs own 5y | 31st | 88th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +32.5% | +19.3% |
| Net profit growth (YoY) | -41.2% | -37.2% |
| Gross margin | 88.9% | 64.2% |
| Operating margin | -68.6% | -33.9% |
| Net margin | -64.7% | -32.5% |
| Return on equity | -43.9% | -30.2% |
| Analyst target vs. price | +11.6% | +11.0% |
| Analyst buy share | 100% | 33% |
| RSI (14) | 52 | 57 |
| 30-day volatility | 58.8% | 66.3% |
| Max drawdown, 1 year | -30.5% | -54.8% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PRCT is the largest of the group by market value.
- CBLL has returned the most over the past year.
- CBLL is growing revenue fastest.
- PRCT keeps the most profit per dollar of sales.
- CBLL has been the calmest stock over the last 30 days.